WO2009085573A3 - Quality control cell device for immunohistochemistry assay and methods of use thereof - Google Patents

Quality control cell device for immunohistochemistry assay and methods of use thereof Download PDF

Info

Publication number
WO2009085573A3
WO2009085573A3 PCT/US2008/085833 US2008085833W WO2009085573A3 WO 2009085573 A3 WO2009085573 A3 WO 2009085573A3 US 2008085833 W US2008085833 W US 2008085833W WO 2009085573 A3 WO2009085573 A3 WO 2009085573A3
Authority
WO
WIPO (PCT)
Prior art keywords
quality control
methods
control sample
cell device
immunohistochemistry assay
Prior art date
Application number
PCT/US2008/085833
Other languages
French (fr)
Other versions
WO2009085573A2 (en
Inventor
Marc E. Key
Original Assignee
Spring Bioscience Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spring Bioscience Corporation filed Critical Spring Bioscience Corporation
Publication of WO2009085573A2 publication Critical patent/WO2009085573A2/en
Publication of WO2009085573A3 publication Critical patent/WO2009085573A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G01N1/31—Apparatus therefor
    • G01N1/312—Apparatus therefor for samples mounted on planar substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B21/00—Microscopes
    • G02B21/34—Microscope slides, e.g. mounting specimens on microscope slides

Abstract

Disclosed herein is a quality control device for an immunohistochemistry assay. The quality control device can include a membrane with a first surface and a quality control sample, such as a cell pellet section. The quality control sample can be immobilized on a detachable surface that allows the quality control sample to be removed and subsequently adhered to a second surface. In an example, the quality control sample includes control cells, such as universal positive control cells. Methods are also provided for preparing and using a quality control device. For example, the methods can include immobilizing a quality control sample on a first surface, whereby the quality control sample includes a cell pellet section and the first surface is a detachable surface.
PCT/US2008/085833 2007-12-28 2008-12-08 Quality control cell device for immunohistochemistry assay and methods of use thereof WO2009085573A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US942007P 2007-12-28 2007-12-28
US936007P 2007-12-28 2007-12-28
US942607P 2007-12-28 2007-12-28
US61/009,426 2007-12-28
US61/009,360 2007-12-28
US61/009,420 2007-12-28

Publications (2)

Publication Number Publication Date
WO2009085573A2 WO2009085573A2 (en) 2009-07-09
WO2009085573A3 true WO2009085573A3 (en) 2009-09-17

Family

ID=40824978

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2008/085833 WO2009085573A2 (en) 2007-12-28 2008-12-08 Quality control cell device for immunohistochemistry assay and methods of use thereof
PCT/US2008/085844 WO2009085576A2 (en) 2007-12-28 2008-12-08 Positive control cell pellets for immunohistochemistry and methods of use thereof
PCT/US2008/085841 WO2009085575A2 (en) 2007-12-28 2008-12-08 Calibrator quality control cell device for immunohistochemistry assay and methods of use thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US2008/085844 WO2009085576A2 (en) 2007-12-28 2008-12-08 Positive control cell pellets for immunohistochemistry and methods of use thereof
PCT/US2008/085841 WO2009085575A2 (en) 2007-12-28 2008-12-08 Calibrator quality control cell device for immunohistochemistry assay and methods of use thereof

Country Status (1)

Country Link
WO (3) WO2009085573A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012023010A8 (en) 2010-03-12 2017-12-26 Immunogen Inc ANTIBODY OR ANTIGEN-BINDING FRAGMENT OF THE SAME THAT SPECIFICALLY BINDS TO CD37, IMMUNOCONJUGATE COMPRISING THE SAME, USE OF THE SAID ANTIBODY, FRAGMENT AND IMMUNOCONJUGATE, COMPOSITION COMPRISING THE SAME, KIT, ISOLATED CELL, AS WELL AS IN VITRO METHOD TO INHIBIT GROWTH MENT OF A CELL THAT EXPRESSES CD37
EA201391342A1 (en) 2011-04-01 2014-11-28 Иммьюноджен, Инк. CD37-BINDING MOLECULES AND THEIR IMMUNOCONJUGATES
SG11201405766SA (en) * 2012-03-30 2014-10-30 Immunogen Inc Methods for increasing efficacy of cd37-based therapy
US20130338014A1 (en) * 2012-04-05 2013-12-19 Vala Sciences, Inc. Calibration Standards For Digital Histocytometry
US20130338016A1 (en) * 2012-04-17 2013-12-19 Vala Sciences, Inc. Method For Integrated Pathology Diagnosis And Digital Biomarker Pattern Analysis
WO2014052876A1 (en) * 2012-09-28 2014-04-03 Immunogen Inc. Methods for increasing efficacy of cd56- based therapy
KR20150136599A (en) 2013-03-30 2015-12-07 클래리언트 다이아그노스틱 서비시즈, 인크. Microscope slides with quality controls thereon
WO2015017535A2 (en) * 2013-08-02 2015-02-05 Siemens Healthcare Diagnostics Inc. Cell-based control and method
CA2986437A1 (en) 2015-06-08 2016-12-15 Debiopharm International, S.A. Anti-cd37 immunoconjugate and anti-cd20 antibody combinations
EA201890347A1 (en) 2015-08-28 2018-09-28 Дебиофарм Интернэшнл, С.А. ANTIBODIES AND RESEARCH FOR DETECTION CD37
CN105241726A (en) * 2015-09-14 2016-01-13 黄小军 Immunohistochemical staining method and applications of immunohistochemical staining method in cervical tumorous lesion screening
JP2020510608A (en) 2016-11-02 2020-04-09 デビオファーム インターナショナル， エス． アー． Method for improving anti-CD37 immunoconjugate therapy
EP3639079A4 (en) * 2017-06-15 2021-02-24 Sunstone Scientific Limited. Process record slide for immunohistochemical staining
JP7440411B2 (en) * 2017-06-15 2024-02-28 シンセン ピーアールエス リミテッド Method of scale extrapolation for IHC antigen imaging
US10921223B2 (en) * 2018-10-12 2021-02-16 Shenzhen Prs Limited Process record slide for staining and method of using the same
GB202006257D0 (en) * 2020-04-28 2020-06-10 Leeds Teaching Hospitals Nhs Trust Stain assessment
CN113515077A (en) * 2021-04-23 2021-10-19 重庆德方信息技术有限公司 System and method for monitoring human body cell staining process
GB2606387A (en) * 2021-05-06 2022-11-09 Futamura Chemical Uk Ltd Device
WO2022259810A1 (en) * 2021-06-07 2022-12-15 株式会社日立ハイテク Control slide glass for pathological examination and method for manufacturing same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005263A1 (en) * 1989-09-26 1991-04-18 City Of Hope Quantitative immunocytochemistry assay
US5846749A (en) * 1994-10-12 1998-12-08 The Regents Of The University Of California Quantitative measurement of tissue protein identified by immunohistochemistry and standardized protein determination
WO2000062064A2 (en) * 1999-04-14 2000-10-19 Cytologix Corporation Quality control for cytochemical assays
US20050003458A1 (en) * 2003-06-12 2005-01-06 Mathew Moore Method and system for the analysis of high density cells samples

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100650162B1 (en) * 2003-08-05 2006-11-27 주식회사 진인 Microarray comprising probes for drug-resistant hepatitis B virus detection, quality control and negative control, and Method for detecting drug-resistant hepatitis B virus using the same
US20070141723A1 (en) * 2005-12-16 2007-06-21 Sompuram Seshi A Immunohistochemistry staining controls

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005263A1 (en) * 1989-09-26 1991-04-18 City Of Hope Quantitative immunocytochemistry assay
US5846749A (en) * 1994-10-12 1998-12-08 The Regents Of The University Of California Quantitative measurement of tissue protein identified by immunohistochemistry and standardized protein determination
WO2000062064A2 (en) * 1999-04-14 2000-10-19 Cytologix Corporation Quality control for cytochemical assays
US20050003458A1 (en) * 2003-06-12 2005-01-06 Mathew Moore Method and system for the analysis of high density cells samples

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
I. PETERSEN ET AL.: "iCon-TMA for control and quantitation of immunohistochemistry and in situ molecular pathology analysis.", PATHOLOGY-RESEARCH AND PRACTICE, vol. 203, 21 June 2007 (2007-06-21), pages 629 - 631, XP022183354, DOI: doi:10.1016/j.prp.2007.04.010 *
J. PACKEISEN ET AL.: "Tissue microarray: a new approach for quality control in immunohistochemistry.", JOURNAL OF CLINICAL PATHOLOGY, vol. 55, 2002, pages 613 - 615 *

Also Published As

Publication number Publication date
WO2009085573A2 (en) 2009-07-09
WO2009085576A2 (en) 2009-07-09
WO2009085575A3 (en) 2009-09-17
WO2009085575A2 (en) 2009-07-09
WO2009085576A3 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
WO2009085573A3 (en) Quality control cell device for immunohistochemistry assay and methods of use thereof
WO2009061442A8 (en) Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells
WO2007008609A3 (en) Methods and apparatus for cell culture array
WO2010034007A3 (en) Methods for detecting a mycobacterium tuberculosis infection
WO2007044418A3 (en) Cell culture media, kits and methods of use
EP2808393A3 (en) Fucosylation-deficient cells
WO2007047825A3 (en) Microfluidic cell culture device and method for using same
WO2007031871A3 (en) Support device for cells culture
CA2680213C (en) Transdermal analyte monitoring systems and methods for analyte detection
WO2007047772A3 (en) Microfluidic cell culture device
EP1788073A4 (en) Porous sheet member for cell culture and, utilizing the same, bioreactor and culturing method
WO2010005843A3 (en) Conversion assemblage for a surface modifying apparatus and method thereof
WO2009092087A3 (en) Selective differentiation, identification, and modulation of human th17 cells
EP2219032A4 (en) Planar lipid-bilayer membrane array using microfluid and analysis method with the use of the planar lipid-bilayer membrane
WO2011116922A3 (en) Thermoreactive substrate with microgels, method for its preparation, and culture method for biological cells
WO2005087915A3 (en) Use of ethanolamine for enhancing cell growth in membrane systems
WO2012018741A3 (en) Pressurizable cartridge for polymerase chain reactions
EP1892295A3 (en) Method and device of isolating and amplifying nucleic acid from microorganism cell using nonplanar solid substrate
WO2010020876A3 (en) Cell culture method to form aggregates
WO2015035239A3 (en) Reagents and methods for screening mps i, ii, iiia, iiib, iva, vi, and vii
WO2010019920A3 (en) Porous materials for biological sample collection
WO2008073901A3 (en) Metal-organic solids for use in proton exchange membranes
WO2007022348A3 (en) Amplification of cell polulations from embryonic stem cells
EP1930430A4 (en) Method for specifically selecting antibody-producing cell
WO2007037910A3 (en) Specific removal of activated immune cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08866964

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08866964

Country of ref document: EP

Kind code of ref document: A2